LONG-TERM HEMODYNAMIC-EFFECTS OF AMLODIPINE AT REST AND DURING EXERCISE IN ESSENTIAL-HYPERTENSION

被引:12
作者
LUNDJOHANSEN, P
OMVIK, P
WHITE, W
DIGRANES, O
HELLAND, B
JORDAL, O
STRAY, T
机构
[1] Medical Department, Section of Cardiology, University of Bergen School of Medicine, Bergen, Haukeland Sykenhus
关键词
HEMODYNAMICS; AMLODIPINE; HYPERTENSION;
D O I
10.1159/000175046
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Haemodynamic responses at rest and during exercise were studied in 18 patients with essential hypertension following long-term treatment with amlodipine. Patients underwent a 2-week placebo run-in period followed by a mean duration of 11 months' treatment with amlodipine 5-10 mg (mean dose 9 mg) once daily. Blood pressure was measured intra-arterially, cardiac output by dye dilution and heart rate by electrocardiogram. Amlodipine produced a mean reduction in systolic and diastolic arterial pressure of 27 and 16 mm Hg, respectively, at rest and after exercise. At rest sitting, mean systolic and diastolic arterial pressures were reduced by 16 and 14 % (p < 0.0 1), respectively, from initial mean values of 182.4/111.2 mm Hg. This reduction in blood pressure was associated with a marked reduction in the total peripheral resistance index of 19% (p < 0.001). Similar responses were observed at rest supine and during exercise. No significant changes were seen in heart rate. Stroke index showed a small increase at rest and during exercise together with a trend towards an increase in cardiac index after treatment with amlodipine. Ambulatory blood pressure monitoring was carried out in 10 patients after the placebo run-in and at the end of the study. Amlodipine showed effective blood pressure control throughout the 24 h after one daily dose. The incidence of side effects was low (ankle oedema in 2 patients).
引用
收藏
页码:37 / 45
页数:9
相关论文
共 29 条
[1]   POSITION OF CALCIUM-ANTAGONISTS IN ANTIHYPERTENSIVE THERAPY [J].
BUHLER, FR ;
BOLLI, P ;
ERNE, P ;
KIOWSKI, W ;
MULLER, FB ;
HULTHEN, UL ;
JI, BH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 :S21-S27
[2]   AMLODIPINE [J].
BURGES, RA ;
DODD, MG .
CARDIOVASCULAR DRUG REVIEWS, 1990, 8 (01) :25-44
[3]   HEMODYNAMIC ASPECTS OF ESSENTIAL-HYPERTENSION IN HUMANS [J].
CONWAY, J .
PHYSIOLOGICAL REVIEWS, 1984, 64 (02) :617-660
[4]   PHYSIOLOGICAL-ASPECTS OF PRIMARY HYPERTENSION [J].
FOLKOW, B .
PHYSIOLOGICAL REVIEWS, 1982, 62 (02) :347-504
[5]  
FRAIS MA, 1986, HERZ, V11, P351
[6]   A DOSE-RESPONSE STUDY OF AMLODIPINE IN MILD TO MODERATE HYPERTENSION [J].
FRICK, MH ;
MCGIBNEY, D ;
TYLER, HM .
JOURNAL OF INTERNAL MEDICINE, 1989, 225 (02) :101-105
[7]   THE ROLE OF CALCIUM-CHANNEL BLOCKERS IN THE TREATMENT OF HYPERTENSION [J].
HALPERIN, AK ;
CUBEDDU, LX .
AMERICAN HEART JOURNAL, 1986, 111 (02) :363-382
[8]   24-H BLOOD-PRESSURE CONTROL WITH THE ONCE DAILY CALCIUM-ANTAGONIST, AMLODIPINE [J].
HEBER, ME ;
BRIGDEN, G ;
ALKHAWAJA, I ;
RAFTERY, EB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (03) :359-365
[9]   AMLODIPINE IN HYPERTENSION - AN OVERVIEW OF THE CLINICAL DOSSIER [J].
JULIUS, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 :S27-S33
[10]   EVALUATION OF LEFT-VENTRICULAR DIASTOLIC FUNCTION - CLINICAL RELEVANCE AND RECENT DOPPLER ECHOCARDIOGRAPHIC INSIGHTS [J].
LABOVITZ, AJ ;
PEARSON, AC .
AMERICAN HEART JOURNAL, 1987, 114 (04) :836-851